Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Pharmacol Exp Ther
2015 Aug 01;3542:184-94. doi: 10.1124/jpet.115.223933.
Show Gene links
Show Anatomy links
Desformylflustrabromine Modulates α4β2 Neuronal Nicotinic Acetylcholine Receptor High- and Low-Sensitivity Isoforms at Allosteric Clefts Containing the β2 Subunit.
Weltzin MM, Schulte MK.
???displayArticle.abstract???
Alterations in expression patterns of α4β2 nicotinic acetylcholine receptors have been demonstrated to alter cholinergic neurotransmission and are implicated in neurologic disorders, including autism, nicotine addiction, Alzheimer's disease, and Parkinson's disease. Positive allosteric modulators (PAMs) represent promising new leads in the development of therapeutic agents for the treatment of these disorders. This study investigates the involvement of the β2-containing subunit interfaces of α4β2 receptors in the modulation of acetylcholine (ACh)-induced responses by the PAM desformylflustrabromine (dFBr). Eight amino acids on the principal face of the β2 subunit were mutated to alanine to explore the involvement of this region in the potentiation of ACh-induced currents by dFBr. ACh-induced responses obtained from wild-type and mutant α4β2 receptors expressed in Xenopus laevis oocytes were recorded in the presence and absence of dFBr using two-electrode voltage clamp electrophysiology. Wild-type and mutant receptors were expressed in both high and low ACh sensitivity isoforms by using biased injection ratios of 1:5 or 5:1 α4 to β2 complementary RNA. Mutations were made in the B, C, and A loops of the principal face of the β2 subunit, which are regions not involved in the binding of ACh. Mutant β2(Y120A) significantly eliminated dFBr potency in both isoform preparations. Several other mutations altered dFBr potentiation levels in both preparations. Our findings support the involvement of the principal face of the β2 subunit in dFBr modulation of ACh-induced responses. Findings from this study will aid in the improved design of dFBr-like PAMs for potential therapeutic use.
Adams,
Evidence for a role of nicotinic acetylcholine receptors in schizophrenia.
2007, Pubmed
Adams,
Evidence for a role of nicotinic acetylcholine receptors in schizophrenia.
2007,
Pubmed Amin,
Two tyrosine residues on the alpha subunit are crucial for benzodiazepine binding and allosteric modulation of gamma-aminobutyric acidA receptors.
1997,
Pubmed
,
Xenbase Aubert,
Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.
1992,
Pubmed Barish,
Calcium buffering and slow recovery kinetics of calcium-dependent outward current in molluscan neurones.
1983,
Pubmed Benson,
Pharmacology of recombinant gamma-aminobutyric acidA receptors rendered diazepam-insensitive by point-mutated alpha-subunits.
1998,
Pubmed Briggs,
Untranslated region-dependent exclusive expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nicotinic acetylcholine receptors.
2006,
Pubmed
,
Xenbase Briggs,
High- and low-sensitivity subforms of alpha4beta2 and alpha3beta2 nAChRs.
2006,
Pubmed Buhr,
Residues at positions 206 and 209 of the alpha1 subunit of gamma-aminobutyric AcidA receptors influence affinities for benzodiazepine binding site ligands.
1997,
Pubmed
,
Xenbase Buhr,
A point mutation in the gamma2 subunit of gamma-aminobutyric acid type A receptors results in altered benzodiazepine binding site specificity.
1997,
Pubmed
,
Xenbase Buhr,
Subtle changes in residue 77 of the gamma subunit of alpha1beta2gamma2 GABAA receptors drastically alter the affinity for ligands of the benzodiazepine binding site.
1997,
Pubmed
,
Xenbase Butt,
Bovine serum albumin enhances nicotinic acetylcholine receptor function in mouse thalamic synaptosomes.
2002,
Pubmed Campo-Soria,
Mechanism of action of benzodiazepines on GABAA receptors.
2006,
Pubmed
,
Xenbase Chothia,
The nature of the accessible and buried surfaces in proteins.
1976,
Pubmed Chrisman,
Intra-subunit flexibility underlies activation and allosteric modulation of neuronal nicotinic acetylcholine receptors.
2014,
Pubmed
,
Xenbase Downing,
Benzodiazepine modulation of partial agonist efficacy and spontaneously active GABA(A) receptors supports an allosteric model of modulation.
2005,
Pubmed Eaton,
The unique α4+/-α4 agonist binding site in (α4)3(β2)2 subtype nicotinic acetylcholine receptors permits differential agonist desensitization pharmacology versus the (α4)2(β2)3 subtype.
2014,
Pubmed
,
Xenbase Goldschen-Ohm,
An epilepsy-related region in the GABA(A) receptor mediates long-distance effects on GABA and benzodiazepine binding sites.
2010,
Pubmed Gotti,
Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits.
2008,
Pubmed Hanson,
Structural mechanisms underlying benzodiazepine modulation of the GABA(A) receptor.
2008,
Pubmed
,
Xenbase Hanson,
Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different.
2008,
Pubmed Harpsøe,
Unraveling the high- and low-sensitivity agonist responses of nicotinic acetylcholine receptors.
2011,
Pubmed Jeanclos,
The chaperone protein 14-3-3eta interacts with the nicotinic acetylcholine receptor alpha 4 subunit. Evidence for a dynamic role in subunit stabilization.
2001,
Pubmed
,
Xenbase Joshi,
A vertical flow chamber for Xenopus oocyte electrophysiology and automated drug screening.
2004,
Pubmed
,
Xenbase Kim,
Synthesis of desformylflustrabromine and its evaluation as an alpha4beta2 and alpha7 nACh receptor modulator.
2007,
Pubmed
,
Xenbase Klapper,
The independent distribution of amino acid near neighbor pairs into polypeptides.
1977,
Pubmed Lavoie,
Direct evidence for diazepam modulation of GABAA receptor microscopic affinity.
1996,
Pubmed Martin-Ruiz,
Molecular analysis of nicotinic receptor expression in autism.
2004,
Pubmed Mazzaferro,
Additional acetylcholine (ACh) binding site at alpha4/alpha4 interface of (alpha4beta2)2alpha4 nicotinic receptor influences agonist sensitivity.
2011,
Pubmed
,
Xenbase Mellor,
Frequency-dependent actions of benzodiazepines on GABAA receptors in cultured murine cerebellar granule cells.
1997,
Pubmed Miledi,
A calcium-dependent transient outward current in Xenopus laevis oocytes.
1982,
Pubmed
,
Xenbase Miledi,
Chloride current induced by injection of calcium into Xenopus oocytes.
1984,
Pubmed
,
Xenbase Moretti,
A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes.
2010,
Pubmed Morlock,
Different residues in the GABAA receptor benzodiazepine binding pocket mediate benzodiazepine efficacy and binding.
2011,
Pubmed
,
Xenbase Moroni,
alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine.
2006,
Pubmed
,
Xenbase Moroni,
Non-agonist-binding subunit interfaces confer distinct functional signatures to the alternate stoichiometries of the alpha4beta2 nicotinic receptor: an alpha4-alpha4 interface is required for Zn2+ potentiation.
2008,
Pubmed
,
Xenbase Moroni,
Stoichiometry and pharmacology of two human alpha4beta2 nicotinic receptor types.
2006,
Pubmed
,
Xenbase Mudo,
Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms.
2007,
Pubmed Nelson,
Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors.
2003,
Pubmed
,
Xenbase Nordberg,
Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.
2001,
Pubmed Picciotto,
Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications.
2001,
Pubmed Pollock,
Cyclic AMP-dependent protein kinase A and protein kinase C phosphorylate alpha4beta2 nicotinic receptor subunits at distinct stages of receptor formation and maturation.
2009,
Pubmed Rose,
Hydrophobicity of amino acid residues in globular proteins.
1985,
Pubmed Rüsch,
Classic benzodiazepines modulate the open-close equilibrium in alpha1beta2gamma2L gamma-aminobutyric acid type A receptors.
2005,
Pubmed
,
Xenbase Sala,
Potentiation of human alpha4beta2 neuronal nicotinic receptors by a Flustra foliacea metabolite.
2005,
Pubmed
,
Xenbase Short,
Subunit interfaces contribute differently to activation and allosteric modulation of neuronal nicotinic acetylcholine receptors.
2015,
Pubmed
,
Xenbase Taly,
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.
2009,
Pubmed Tapia,
Ca2+ permeability of the (alpha4)3(beta2)2 stoichiometry greatly exceeds that of (alpha4)2(beta2)3 human acetylcholine receptors.
2007,
Pubmed
,
Xenbase Teissére,
A (beta)-strand in the (gamma)2 subunit lines the benzodiazepine binding site of the GABA A receptor: structural rearrangements detected during channel gating.
2001,
Pubmed
,
Xenbase Thompson,
Mutation at the putative GABA(A) ion-channel gate reveals changes in allosteric modulation.
1999,
Pubmed
,
Xenbase Wagner,
Structure and dynamics of the GABA binding pocket: A narrowing cleft that constricts during activation.
2001,
Pubmed
,
Xenbase Weltzin,
Pharmacological characterization of the allosteric modulator desformylflustrabromine and its interaction with alpha4beta2 neuronal nicotinic acetylcholine receptor orthosteric ligands.
2010,
Pubmed
,
Xenbase Weltzin,
Allosteric modulation of alpha4beta2 nicotinic acetylcholine receptors by HEPES.
2014,
Pubmed
,
Xenbase Wieland,
A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.
1992,
Pubmed Zhou,
Human alpha4beta2 acetylcholine receptors formed from linked subunits.
2003,
Pubmed
,
Xenbase Zwart,
Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes.
1998,
Pubmed
,
Xenbase Zwart,
5-I A-85380 and TC-2559 differentially activate heterologously expressed alpha4beta2 nicotinic receptors.
2006,
Pubmed
,
Xenbase
